This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Owens & Minor (OMI) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Owens & Minor (OMI) has been struggling lately, but the selling pressure may be coming to an end soon.
Agios' (AGIO) Mitapivat Gets Orphan Drug Tag to Treat SCD
by Zacks Equity Research
The FDA confers an orphan drug status on Agios' (AGIO) pyruvate kinase-R activator mitapivat for addressing sickle cell disease. Stock climbs in after-hours trading.
Zacks.com featured highlights include: Kontoor Brands, Camping World, General Motors and Owens & Minor
by Zacks Equity Research
Zacks.com featured highlights include: Kontoor Brands, Camping World, General Motors and Owens & Minor
Top Ranked Growth Stocks to Buy for November 12th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, November 12th.
Want to Bet on High Earnings Yield Stocks? Check Out These
by Rimmi Singhi
While comparing stocks, if other factors are similar, the one with higher earnings yield is considered undervalued.
Owens & Minor's (OMI) Shares Fall Despite Q3 Earnings Beat
by Zacks Equity Research
Owens & Minor (OMI) reports solid revenue growth in its Global Products arm in the third quarter due to strength in PPE sales.
Top Ranked Growth Stocks to Buy for November 10th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, November 10th
Zacks.com featured highlights include: Merit Medical Systems, Brinker International, Group 1 Automotive, Owens & Minor and HomeStreet
by Zacks Equity Research
Zacks.com featured highlights include: Merit Medical Systems, Brinker International, Group 1 Automotive, Owens & Minor and HomeStreet
The Zacks Analyst Blog Highlights: United Natural Foods, The Boston Beer Company, DaVita, Owens & Minor and Primo Water Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: United Natural Foods, The Boston Beer Company, DaVita, Owens & Minor and Primo Water Corp
6 Stocks Near 52-Week Highs Poised to Appreciate Further
by Anirudha Bhagat
Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.
Top Ranked Growth Stocks to Buy for November 3rd
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, November 3rd
Owens & Minor (OMI) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Owens & Minor (OMI) delivered earnings and revenue surprises of 15.71% and 5.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
5 Safe Stocks to Sail Through the US Election Uncertainties
by Sreoshi Bera
Rise in coronavirus cases and uncertainties revolving around the election might keep markets volatile for some time. Here are five stocks to invest in and play safe.
Tivity Health (TVTY) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Strength in digital branding is likely to have aided Tivity Health's (TVTY) performance in the third quarter of 2020 amid coronavirus-led economic doldrums.
Top Ranked Growth Stocks to Buy for October 29th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, October 29th.
Owens & Minor (OMI) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Owens & Minor's (OMI) PPE sales are likely to have maintained its momentum during Q3, thus driving the top line.
Will Owens & Minor (OMI) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Owens & Minor (OMI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Top Ranked Growth Stocks to Buy for October 28th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 28th
Owens & Minor (OMI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Big Lots, BBBY, AAR, Beazer Homes and Owens & Minor
by Zacks Equity Research
Zacks.com featured highlights include: Big Lots, BBBY, AAR, Beazer Homes and Owens & Minor
Agios (AGIO) Withdraws Filing for Leukemia Drug Tibsovo in EU
by Zacks Equity Research
Agios (AGIO) withdraws the regulatory filing for Tibsovo in Europe, which was developed to treat relapsed/refractory acute myeloid leukemia in adult patients with a susceptible IDH1 mutation.
5 Stocks Stealing the Limelight Post Recent Analyst Upgrade
by Maharathi Basu
Broker-favorite stocks like Big Lots (BIG), Bed Bath & Beyond (BBBY), AAR (AIR), Owens & Minor (OMI) and Beazer Homes (BZH) should be on an investor's watchlist in the quest for handsome returns.
Top Ranked Growth Stocks to Buy for October 19th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 19th
Zacks.com featured highlights include: Group 1 Automotive, Owens & Minor, TRI Pointe, Target and Best Buy
by Zacks Equity Research
Zacks.com featured highlights include: Group 1 Automotive, Owens & Minor, TRI Pointe, Target and Best Buy
Levi Strauss, Vail Resorts, Ensign, Owens & Minor and RPM as Zacks Bull and Bear of the Day
by Zacks Equity Research
Levi Strauss, Vail Resorts, Ensign, Owens & Minor and RPM as Zacks Bull and Bear of the Day